Prevention of duodenal ulcers in the rat using a combination of ranitidine and sucralphate in subtherapeutic doses.

This study investigated whether ulcer prevention would be greater with the combined use of an acid-inhibiting agent, ranitidine, given together with a mucosal-protective agent, sucralphate. Duodenal ulcers were induced in rats with the secretagogues pentagastrin and bethanechol. Subtherapeutic doses of ranitidine (5 mg/kg/6 hours) and sucralphate (50 mg/6 hour) yielded an ulcer index of 4.

Comparison of electrophoretic isoamylase patterns among various species.

The electrophoretic pattern of isoamylase in the serum, urine, pancreas, salivary gland, liver, and small intestine of the dog, pig, rat, hamster, and prairie dog was compared to man. Great species variation in isoamylase patterns was noted. These variations should be kept in mind when studying pancreatic disease in species other than man.

Prevention of experimental duodenal ulcer in the rat by sucralfate.

We examined the ability of sucralfate to prevent secretagogue induced duodenal ulcer in the rat. Sucralfate was administered orally in dosage schedules of 50 mg, 100 mg or 200 mg before and at 3 and 6 hr after commencing a 24 hr continuous infusion of pentagastrin and bethanechol. The animals were sacrificed at 24 hr and the number and severity of ulcers was scored.